Future studies using other CML cell lines and animal models in vivo could ascertain whether the impact of UA on Gfi-1/Stat5/Akt pathway is a general proapoptotic-action mechanism and possibly shows novel therapeutic applications. This evidence concerns the gene GFI1 and chronic myelogenous leukemia, BCR-ABL1 positive.